SCHEMBL6894568

SCHEMBL6894568

CC(C)CCNC(c1ccccc1)C(N)C(C)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.44
ADRA2A P08913 2/20 0.44
LMNA P02545 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
HTR1A P08908 2/20 0.44
ADORA3 P0DMS8 2/20 0.44
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
ADRA1A P35348 2/20 0.44
OPRM1 P35372 2/20 0.44
DRD3 P35462 2/20 0.44
SLC6A3 Q01959 2/20 0.44
KCNH2 Q12809 2/20 0.44
CHRM2 P08172 1/20 0.44
CHRM1 P11229 1/20 0.44
SMPD1 P17405 1/20 0.44
DRD1 P21728 1/20 0.44
TBXA2R P21731 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6894924 0.84 KDM4E (0.43) ADRA2ALMNAALDH1A1ANPEPAOC3
SCHEMBL6889436 0.83 SIGMAR1 (0.49) CYP3A4ADRA2ALMNACYP1A2CYP2D6
SCHEMBL6895074 0.82 HPGD (0.44) ADRA2ALMNAALDH1A1ANPEPAOC3
SCHEMBL6895263 0.81 KDM4E (0.43) ADRA2ALMNACYP1A2CYP2D6ALDH1A1
SCHEMBL6887458 0.81 SIGMAR1 (0.51) CYP2D6CYP2C19KCNH2KMT2ACNR1
SCHEMBL6890858 0.80 SIGMAR1 (0.50) LMNACYP2D6HTR1AADRA1ADRD3
SCHEMBL6896045 0.80 ALDH1A1 (0.49) ADRA2ALMNAALDH1A1SMN1; SMN2MEN1
SCHEMBL6895745 0.79 LMNA (0.47) ADRA2ALMNACYP1A2CYP2D6CYP2C19
SCHEMBL6896012 0.79 PSEN1 (0.30) HTR2A
SCHEMBL6890899 0.79 AOC3 (0.36) ADRA2ALMNAALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed